A phase II, multicenter, open-label study of YM155 plus docetaxel in subjects with stage III (unresectable) or stage IV melanoma
Steinberg, Joyce Leta, Bedikian, Agop Y., Ernst, D. Scott, Chmielowski, Bartosz, Redman, Bruce, Keating, Anne Therese, Jie, Fei, Chen, Caroline, Weber, Jeffrey S., Kudchadkar, Ragini Reiney
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Phase I/II trial of PD-1 antibody nivolumab with peptide vaccine in patients naive to or that failed ipilimumab
Weber, Jeffrey S., Kudchadkar, Ragini Reiney, Gibney, Geoffrey Thomas, De Conti, Ronald C., Yu, Bin, Wang, Wenshi, Sarnaik, Amod, Martinez, Alberto J, Kroeger, Jodi, Eysmans, Cabell, Gallenstein, Donna, Zhao, Xiuhua, Chen, Ann
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
A phase III open-label study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) versus investigator’s choice in advanced melanoma patients progressing post anti-CTLA-4 therapy
Chmielowski, Bartosz, Hamid, Omid, Minor, David R., D'Angelo, Sandra P., Pennock, Gregory K., Grossmann, Kenneth, Ascierto, Paolo Antonio, Daud, Adil, Dummer, Reinhard, Hodi, F. Stephen, Lebbé, Céleste, Robert, Caroline, Sosman, Jeffrey Alan, Yang, Arvin, Lambert, Alexandre, Weber, Jeffrey S.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Ipilimumab versus placebo after complete resection of stage III melanoma: Initial efficacy and safety results from the EORTC 18071 phase III trial
Eggermont, Alexander M., Chiarion-Sileni, Vanna, Grob, Jean Jacques, Dummer, Reinhard, Wolchok, Jedd D., Schmidt, Henrik, Hamid, Omid, Robert, Caroline, Ascierto, Paolo Antonio, Richards, Jon M., Lebbe, Celeste, Ferraresi, Virginia, Smylie, Michael, Weber, Jeffrey S., Maio, Michele, Konto, Cyril, Karra Gurunath, Ravichandra, de Pril, Veerle, Suciu, Stefan, Testori, Alessandro
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Evaluation of immune-related response criteria (irRC) in patients (pts) with advanced melanoma (MEL) treated with the anti-PD-1 monoclonal antibody MK-3475
Hodi, F. Stephen, Ribas, Antoni, Daud, Adil, Hamid, Omid, Robert, Caroline, Kefford, Richard, Hwu, Wen-Jen, Gangadhar, Tara C., Joshua, Anthony M., Hersey, Peter, Weber, Jeffrey S., Dronca, Roxana Stefania, Perrone, Andrea Marie, Gammage, Linda, Hille, Darcy, Xue, Dahai, Kang, Soonmo Peter, Chun, Patrick, Ebbinghaus, Scot, Wolchok, Jedd D.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Baseline tumor size as an independent prognostic factor for overall survival in patients with metastatic melanoma treated with the anti-PD-1 monoclonal antibody MK-3475
Joseph, Richard Wayne, Elassaiss-Schaap, Jeroen, Wolchok, Jedd D., Joshua, Anthony M., Ribas, Antoni, Hodi, F. Stephen, Hamid, Omid, Robert, Caroline, Daud, Adil, Hwu, Wen-Jen, Kefford, Richard, Hersey, Peter, Weber, Jeffrey S., Patnaik, Amita, De Alwis, Dinesh Prasad, Perrone, Andrea Marie, Kang, Soonmo Peter, Ebbinghaus, Scot, Anderson, Keaven M., Gangadhar, Tara C.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Updated overall survival (OS) for BRF113220, a phase 1-2 study of dabrafenib (D) alone versus combined dabrafenib and trametinib (D+T) in pts with BRAF V600 mutation-positive (+) metastatic melanoma (MM)
Flaherty, Keith, Daud, Adil, Weber, Jeffrey S., Sosman, Jeffrey Alan, Kim, Kevin, Gonzalez, Rene, Hamid, Omid, Infante, Jeffrey R., Cebon, Jonathan S., Schuchter, Lynn Mara, Long, Georgina V., Algazi, Alain Patrick, Kudchadkar, Ragini Reiney, Puzanov, Igor, Lawrence, Donald P., Kline, Amy S., Cunningham, Elizabeth Ann, Sun, Peng, Patel, Kiran, Kefford, Richard
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Efficacy and safety of the anti-PD-1 monoclonal antibody MK-3475 in 411 patients (pts) with melanoma (MEL)
Ribas, Antoni, Hodi, F. Stephen, Kefford, Richard, Hamid, Omid, Daud, Adil, Wolchok, Jedd D., Hwu, Wen-Jen, Gangadhar, Tara C., Patnaik, Amita, Joshua, Anthony M., Hersey, Peter, Weber, Jeffrey S., Dronca, Roxana Stefania, Zarour, Hassane M., Gergich, Kevin, Li, Xiaoyun (Nicole), Iannone, Robert, Kang, Soonmo Peter, Ebbinghaus, Scot, Robert, Caroline
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Clinical efficacy and correlation with tumor PD-L1 expression in patients (pts) with melanoma (MEL) treated with the anti-PD-1 monoclonal antibody MK-3475
Kefford, Richard, Ribas, Antoni, Hamid, Omid, Robert, Caroline, Daud, Adil, Wolchok, Jedd D., Joshua, Anthony M., Hodi, F. Stephen, Gangadhar, Tara C., Hersey, Peter, Weber, Jeffrey S., Dronca, Roxana Stefania, Patnaik, Amita, Zarour, Hassane M., Dolled-Filhart, Marisa, Lunceford, Jared, Emancipator, Kenneth, Ebbinghaus, Scot, Kang, Soonmo Peter, Hwu, Wen-Jen
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Randomized comparison of two doses of the anti-PD-1 monoclonal antibody MK-3475 for ipilimumab-refractory (IPI-R) and IPI-naive (IPI-N) melanoma (MEL)
Hamid, Omid, Robert, Caroline, Ribas, Antoni, Wolchok, Jedd D., Hodi, F. Stephen, Kefford, Richard, Joshua, Anthony M., Hwu, Wen-Jen, Gangadhar, Tara C., Patnaik, Amita, Hersey, Peter, Weber, Jeffrey S., Joseph, Richard Wayne, Gergich, Kevin, Li, Xiaoyun (Nicole), Chun, Patrick, Ebbinghaus, Scot, Kang, Soonmo Peter, Daud, Adil
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Abstract 3170: Identification of novel genetic alterations driving melanoma tumorigenesis
Kim, Minjung, Ding, Li, Dees, Nathan, Kanchi, Krishna L., Sung, Hyeran, Fenstermacher, David, Griffith, Malachi, Linette, Gerry, Cornelius, Lynn, Sondak, Vernon K., Mulé, James J., Wilson, Richard K., Weber, Jeffrey S.
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
Abstract 5246: Histone deacetylase 6 (HDAC6) as a new modulator of the JAK/STAT pathway in melanoma
Lienlaf, Maritza, Perez-Villarroel, Patricio, Canales, Jorge, Knox, Tessa, Cheng, Fengdong, Marante, Danay, Woods, David, Woan, Karrune, Wang, HongWei, Seto, Ed, Weber, Jeffrey S., Sotomayor, Eduardo M., Villagra, Alejandro
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
Combined BRAF (Dabrafenib) and MEK Inhibition (Trametinib) in Patients With BRAF V600 -Mutant Melanoma Experiencing Progression With Single-Agent BRAF Inhibitor
Johnson, Douglas B., Flaherty, Keith T., Weber, Jeffrey S., Infante, Jeffrey R., Kim, Kevin B., Kefford, Richard F., Hamid, Omid, Schuchter, Lynn, Cebon, Jonathan, Sharfman, William H., McWilliams, Robert R., Sznol, Mario, Lawrence, Donald P., Gibney, Geoffrey T., Burris, Howard A., Falchook, Gerald S., Algazi, Alain, Lewis, Karl, Long, Georgina V., Patel, Kiran, Ibrahim, Nageatte, Sun, Peng, Little, Shonda, Cunningham, Elizabeth, Sosman, Jeffrey A., Daud, Adil, Gonzalez, Rene
Published in Journal of clinical oncology (20.11.2014)
Published in Journal of clinical oncology (20.11.2014)
Get full text
Journal Article
Abstract 1807: Tumor-infilitrating lymphocytes derived from pancreatic adenocarcinoma exhibit an activated, pro-inflammatory phenotype
Hall, MacLean S., Centeno, Barbara, Malafa, Mokenge, Hodul, Pamela J., Weber, Jeffrey S., Pilon-Thomas, Shari, Sarnaik, Amod A.
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Get full text
Journal Article
Clinical experience of a targeted TCR-IL2 fusion protein in combination with cisplatin (CDDP) in patients (pts) with metastatic melanoma
Milhem, Mohammed M., Weber, Jeffrey S., Amin, Asim, Agarwala, Sanjiv S, Lawson, David H., Thompson, John A., O'Day, Steven, Pennock, Gregory K., Richards, Jon M., Kuzel, Timothy, Hernandez, Liza, Huang, Bee-Yau, Rhode, Peter, Wong, Hing C.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Early outcome results of a phase I/II study for an IL-2/T-cell receptor fusion protein in combination with gemcitabine and cisplatin (GC) in patients with locally advanced or metastatic urothelial cancer
Hajdenberg, Julio, Landau, Danny, Vaena, Daniel A., Fishman, Mayer N., Rosser, Charles Joel, Milhem, Mohammed M., Weber, Jeffrey S., Rizzo, Virginia, Zehr, Pamela, Williams-Elson, Irene, Rhode, Peter, Schutt, Tessa, Hernandez, Liza, Huang, Bee-Yau, Wong, Hing C.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Ipilimumab (Ipi) expanded access program (EAP) for patients (pts) with stage III/IV melanoma: 10 mg/kg cohort interim results
Hamid, Omid, Hwu, Wen-Jen, Richards, Jon M., Weber, Jeffrey S., Wolchok, Jedd D., Sznol, Mario, Minor, David R., Pavlick, Anna C., Urba, Walter John, Hodi, F. Stephen, Yang, Arvin, Michener, Tracy, Balogh, Agnes, McDermott, David F.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
BRAF inhibitor (BRAFi) dabrafenib in combination with the MEK1/2 inhibitor (MEKi) trametinib in BRAFi-naive and BRAFi-resistant patients (pts) with BRAF mutation-positive metastatic melanoma (MM)
Sosman, Jeffrey Alan, Daud, Adil, Weber, Jeffrey S., Kim, Kevin, Kefford, Richard, Flaherty, Keith, Infante, Jeffrey R., Hamid, Omid, Cebon, Jonathan S., Schuchter, Lynn Mara, McWilliams, Robert R., Sznol, Mario, Sharfman, William Howard, Algazi, Alain Patrick, Lewis, Karl D., Little, Shonda M, Sun, Peng, Long, Georgina, Patel, Kiran, Gonzalez, Rene
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article